Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Go back to Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity| (NASDAQ: CRBP) | Delayed: 7.54 +0.06 (0.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.48 | 52 Week High | $10.78 | |||
| Open | $7.51 | 52 Week Low | $1.01 | |||
| Day High | $7.79 | P/E | N/A | |||
| Day Low | $7.42 | EPS | $0.00 | |||
| Volume | 223,176 | |||||
